These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8086122)

  • 1. Azithromycin and clarithromycin.
    Eisenberg E; Barza M
    Curr Clin Top Infect Dis; 1994; 14():52-79. PubMed ID: 8086122
    [No Abstract]   [Full Text] [Related]  

  • 2. The newer macrolides: azithromycin and clarithromycin.
    Zuckerman JM
    Infect Dis Clin North Am; 2000 Jun; 14(2):449-62, x. PubMed ID: 10829265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolides in dermatology.
    Scheinfeld NS; Tutrone WD; Torres O; Weinberg JM
    Dis Mon; 2004 Jul; 50(7):350-68. PubMed ID: 15280867
    [No Abstract]   [Full Text] [Related]  

  • 4. Azithromycin and clarithromycin.
    Schlossberg D
    Med Clin North Am; 1995 Jul; 79(4):803-15. PubMed ID: 7791424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
    Kuehne JJ; Yu AL; Holland GN; Ramaswamy A; Taban R; Mondino BJ; Yu F; Rayner SA; Giese MJ
    Am J Ophthalmol; 2004 Oct; 138(4):547-53. PubMed ID: 15488779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    Gill CJ; Abruzzo GK; Flattery AM; Smith JG; Jackson J; Kong L; Wilkening R; Shankaran K; Kropp H; Bartizal K
    J Antibiot (Tokyo); 1995 Oct; 48(10):1141-7. PubMed ID: 7490222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Principi N; Esposito S
    Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: a randomized controlled trial.
    Cascio A; Colomba C; Antinori S; Paterson DL; Titone L
    Clin Infect Dis; 2002 Jan; 34(2):154-8. PubMed ID: 11740701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sumamed--efficacy and convenience].
    Sirakov M; Ivanov S
    Akush Ginekol (Sofiia); 2005; 44 Suppl 2():38-42. PubMed ID: 16028403
    [No Abstract]   [Full Text] [Related]  

  • 10. The new macrolides. Azithromycin and clarithromycin.
    Kanatani MS; Guglielmo BJ
    West J Med; 1994 Jan; 160(1):31-7. PubMed ID: 8128699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
    Kelley MA; Weber DJ; Gilligan P; Cohen MS
    Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
    Peltier K
    Conn Med; 1992 Jul; 56(7):371-4. PubMed ID: 1330429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Newly approved specialty drugs in Austria and new knowledge about currently available specialty drugs. Zithromax capsules, dried syrup].
    Wien Klin Wochenschr; 1994; 106(17):563-71. PubMed ID: 7975673
    [No Abstract]   [Full Text] [Related]  

  • 14. Azithromycin and clarithromycin.
    Hammerschlag MR
    Pediatr Ann; 1993 Mar; 22(3):160, 162-4, 166. PubMed ID: 8385308
    [No Abstract]   [Full Text] [Related]  

  • 15. Two new macrolide antibiotics: clarithromycin and azithromycin.
    Holdcroft C
    Nurse Pract; 1993 Jan; 18(1):50, 53. PubMed ID: 8380492
    [No Abstract]   [Full Text] [Related]  

  • 16. Clarithromycin and azithromycin.
    Med Lett Drugs Ther; 1992 May; 34(870):45-7. PubMed ID: 1315414
    [No Abstract]   [Full Text] [Related]  

  • 17. Clarithromycin and azithromycin.
    Klein JO
    Pediatr Infect Dis J; 1998 Jun; 17(6):516-7. PubMed ID: 9655546
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of newer macrolides.
    Nightingale CH
    Pediatr Infect Dis J; 1997 Apr; 16(4):438-43. PubMed ID: 9109156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
    Hoban DJ; Zhanel GG
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution and role of macrolides in infectious diseases.
    Blondeau JM
    Expert Opin Pharmacother; 2002 Aug; 3(8):1131-51. PubMed ID: 12150692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.